The Treatment of Amyotrophic Lateral Sclerosis With Huollingshengji Granules

Inclusion Criteria

• •1. Meet the Western diagnostic criteria for amyotrophic lateral sclerosis (ALS) (clinically confirmed ALS, clinically likely ALS or clinically likely ALS- laboratory support);
• •2. The score of the modified amyotrophic lateral sclerosis function scale (ALSFRS-R) was ≥2 points for each item (among which dyspnea, sitting breathing and respiratory insufficiency were all 4 points);
• •3. The percentage of forced vital capacity in the predicted value (FVC%) ≥70%;
• •4. the duration of the disease is 3 years or less (from the first onset of any symptoms of ALS);
• •5. TCM syndrome differentiation for deficiency of temper, kidney Yang deficiency syndrome;
• •6. Age 45-70 (including 45 and 70), gender unlimited;
• •7. Voluntarily participate in the clinical trial, give informed consent and sign informed consent.